KRAS and lung carcinoma: However, the data from Figure 3 suggests that lung cancers from both genotypes appear to have a similar response to 7.3 Gy × 2, but there may be an increased response of lung cancers in LSL-Kras; p53FL/FL mice to a single-dose of 11.6 Gy.